- Home
- CGEN vs LFVN Comparison
CGEN vs LFVN Comparison
Compare CGEN & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- LFVN
- Stock Information
- Founded
- CGEN 1993
- LFVN N/A
- Country
- CGEN Israel
- LFVN United States
- Employees
- CGEN N/A
- LFVN N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- CGEN Health Care
- LFVN Health Care
- Exchange
- CGEN Nasdaq
- LFVN Nasdaq
- Market Cap
- CGEN 125.3M
- LFVN 145.2M
- IPO Year
- CGEN 2000
- LFVN N/A
- Fundamental
- Price
- CGEN $1.65
- LFVN $6.59
- Analyst Decision
- CGEN
- LFVN Strong Buy
- Analyst Count
- CGEN 0
- LFVN 2
- Target Price
- CGEN N/A
- LFVN $30.50
- AVG Volume (30 Days)
- CGEN 324.9K
- LFVN 172.4K
- Earning Date
- CGEN 11-10-2025
- LFVN 11-04-2025
- Dividend Yield
- CGEN N/A
- LFVN 2.71%
- EPS Growth
- CGEN N/A
- LFVN 143.91
- EPS
- CGEN N/A
- LFVN 0.78
- Revenue
- CGEN $6,903,000.00
- LFVN $228,877,000.00
- Revenue This Year
- CGEN N/A
- LFVN $6.93
- Revenue Next Year
- CGEN $208.08
- LFVN $1.43
- P/E Ratio
- CGEN N/A
- LFVN $8.51
- Revenue Growth
- CGEN N/A
- LFVN 16.77
- 52 Week Low
- CGEN $1.13
- LFVN $6.38
- 52 Week High
- CGEN $2.66
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- CGEN 46.42
- LFVN 30.22
- Support Level
- CGEN $1.54
- LFVN $6.52
- Resistance Level
- CGEN $1.79
- LFVN $7.47
- Average True Range (ATR)
- CGEN 0.11
- LFVN 0.56
- MACD
- CGEN -0.01
- LFVN -0.04
- Stochastic Oscillator
- CGEN 34.62
- LFVN 9.80
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.